Paul Berg - Net Worth and Insider Trading

Paul Berg Net Worth

The estimated net worth of Paul Berg is at least $5 Million dollars as of 2024-04-19. Paul Berg is the Director of Gilead Sciences Inc and owns about 64,000 shares of Gilead Sciences Inc (GILD) stock worth over $4 Million. Paul Berg is also the Director of Affymetrix Inc and owns about 63,536 shares of Affymetrix Inc (AFFX) stock worth over $890,139. Details can be seen in Paul Berg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul Berg has not made any transactions after 2010-12-14 and currently still holds the listed stock(s).

Transaction Summary of Paul Berg

To

Paul Berg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Berg owns 2 companies in total, including Gilead Sciences Inc (GILD) , and Affymetrix Inc (AFFX) .

Click here to see the complete history of Paul Berg’s form 4 insider trades.

Insider Ownership Summary of Paul Berg

Ticker Comapny Transaction Date Type of Owner
GILD Gilead Sciences Inc 2010-12-14 director
AFFX Affymetrix Inc 2010-05-14 director

Paul Berg Latest Holdings Summary

Paul Berg currently owns a total of 2 stocks. Among these stocks, Paul Berg owns 64,000 shares of Gilead Sciences Inc (GILD) as of December 14, 2010, with a value of $4 Million and a weighting of 82.63%. Paul Berg also owns 63,536 shares of Affymetrix Inc (AFFX) as of July 26, 2005, with a value of $890,139 and a weighting of 17.37%.

Latest Holdings of Paul Berg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GILD Gilead Sciences Inc 2010-12-14 64,000 66.16 4,234,240
AFFX Affymetrix Inc 2005-07-26 63,536 14.01 890,139

Holding Weightings of Paul Berg


Paul Berg Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Berg has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 40,000 shares on December 14, 2010, which brought Paul Berg around $738,600.

According to the SEC Form 4 filings, Paul Berg has made a total of 0 transactions in Affymetrix Inc (AFFX) over the past 5 years. The most-recent trade in Affymetrix Inc is the sale of 3,666 shares on July 26, 2005, which brought Paul Berg around $167,390.

Insider Trading History of Paul Berg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Berg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul Berg Ownership Network

Ownership Network List of Paul Berg

No Data

Ownership Network Relation of Paul Berg


Paul Berg Owned Company Details

What does Gilead Sciences Inc do?

Who are the key executives at Gilead Sciences Inc?

Paul Berg is the director of Gilead Sciences Inc. Other key executives at Gilead Sciences Inc include Chief Medical Officer Merdad Parsey , EVP & Chief Financial Officer Andrew D Dickinson , and Chief Commercial Officer Johanna Mercier .

Gilead Sciences Inc (GILD) Insider Trades Summary

Over the past 18 months, Paul Berg made no insider transaction in Gilead Sciences Inc (GILD). Other recent insider transactions involving Gilead Sciences Inc (GILD) include a net sale of 34,326 shares made by Merdad Parsey , a net sale of 15,000 shares made by Andrew D Dickinson , and a net sale of 22,671 shares made by Diane E. Wilfong .

In summary, during the past 3 months, insiders sold 12,230 shares of Gilead Sciences Inc (GILD) in total and bought 0 shares, with a net sale of 12,230 shares. During the past 18 months, 80,239 shares of Gilead Sciences Inc (GILD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 80,239 shares.

Gilead Sciences Inc (GILD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Gilead Sciences Inc Insider Transactions

No Available Data

Paul Berg Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Berg. You might contact Paul Berg via mailing address: Stanford University School Of Medicine, #b062, Stanford Ca 94305.

Discussions on Paul Berg

No discussions yet.